Protalix BioTherapeutics
PLX
#9004
Rank
NZ$0.37 B
Marketcap
NZ$4.62
Share price
-0.19%
Change (1 day)
44.81%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2026 (TTM): NZ$36.02 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$76.38 Million. In 2025 the company made an earning of -NZ$7.41 Million a decrease over its 2024 earnings that were of NZ$9.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$36.02 M-586.62%
2025 -NZ$7.41 Million-181.6%
2024 NZ$9.07 M-55.62%
2023 NZ$20.44 M-199.05%
2022 -NZ$20.65 Million-40.38%
2021 -NZ$34.63 Million-732.31%
2020 NZ$5.47 M-130.53%
2019 -NZ$17.94 Million189.85%
2018 -NZ$6.19 Million-95.29%
2017 -NZ$0.14 Billion308.12%
2016 -NZ$32.2 Million-32.37%
2015 -NZ$47.61 Million10.11%
2014 -NZ$43.24 Million-7.59%
2013 -NZ$46.79 Million
2011 -NZ$54.18 Million-19.39%
2010 -NZ$67.22 Million20.87%
2009 -NZ$55.61 Million32.26%
2008 -NZ$42.05 Million-5.46%
2007 -NZ$44.47 Million
2004 -NZ$0.29 Million12.35%
2003 -NZ$0.26 Million-11.1%
2002 -NZ$0.29 Million-57.03%
2001 -NZ$0.68 Million1.03%
2000 -NZ$0.67 Million-53.22%
1999 -NZ$1.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.42 B 50,808.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.38 B 3,739.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.33 M-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.94 B 10,816.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel